LSIA
SANA icon

LaSalle St. Investment Advisors’s Sana Biotechnology SANA Stock Holding History

LaSalle St. Investment Advisors’s Portfolio SANA Stock Details SANA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$63.4K Buy
22,000
+1,500
+7% +$5.91K 0.01% 406
2025
Q4 		$83K Buy
20,500
+3,500
+21% +$15.7K 0.01% 362
2025
Q3 		$60K Buy
+17,000
New +$61.5K 0.01% 350

Other funds holding SANA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
MG
Marex Group London $15.8B AUM 31.44% 1-Year Est. Return
IHAM
Integral Health Asset Management New York $2.09B AUM 112.84% 1-Year Est. Return

LaSalle St. Investment Advisors's SANA Position: Q1 2026 in Review

LaSalle St. Investment Advisors increased its Sana Biotechnology (SANA) stake by 7.3% in Q1 2026, buying an estimated $5.91K and bringing the position to 22,000 shares worth $63.4K. The position accounts for 0.01% of the portfolio, ranked #406.

LaSalle St. Investment Advisors first reported a position in SANA in Q3 2025 and has held it in 3 quarters since. The position peaked at $83K in Q4 2025. 202 funds tracked by Wall St. Rank hold SANA as of Q1 2026.

  • LaSalle St. Investment Advisors held 22,000 shares of Sana Biotechnology worth $63.4K as of Q1 2026.
  • LaSalle St. Investment Advisors bought 1,500 Sana Biotechnology shares in Q1 2026, an estimated $5.91K.
  • Sana Biotechnology made up 0.01% of LaSalle St. Investment Advisors's portfolio in Q1 2026, its #406 holding.
  • LaSalle St. Investment Advisors first reported a position in Sana Biotechnology in Q3 2025 and has held it in 3 quarters since.
  • LaSalle St. Investment Advisors's Sana Biotechnology position peaked at $83K in Q4 2025.
  • 202 funds tracked by Wall St. Rank held Sana Biotechnology as of Q1 2026.

Based on LaSalle St. Investment Advisors's 13F filing for Q1 2026, filed 8 May 2026.